Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-16985
Ann Neurol 1997 Feb 01;412:238-46. doi: 10.1002/ana.410410215.
Show Gene links Show Anatomy links

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia.

Hart IK , Waters C , Vincent A , Newland C , Beeson D , Pongs O , Morris C , Newsom-Davis J .


???displayArticle.abstract???
Antibody-mediated autoimmunity underlies a diverse range of disorders, particularly in the nervous system where the extracellular domains of ion channels and receptors are especially vulnerable targets. We present here a novel means of detecting autoantibodies where the genes of the suspected target proteins are known, and use it to detect specific autoantibodies in acquired neuromyotonia (Isaacs' syndrome), a disorder characterized by hyperexcitable motor nerves and sometimes by central abnormalities. We expressed different human brain voltage-gated potassium channels in Xenopus oocytes by injecting the relevant alpha-subunit complementary RNA, and detected antibody binding by immunohistochemistry on frozen sections. Antibodies were detected to one or more human brain voltage-gated potassium channel in 12 of 12 neuromyotonia patients and none of 18 control subjects. The results establish neuromyotonia as a new antibody-mediated channelopathy and indicate the investigative potential of this molecular immunohistochemical assay.

???displayArticle.pubmedLink??? 9029073
???displayArticle.link??? Ann Neurol